Skip to main content
Journal cover image

Regression of tumors in mice vaccinated with professional antigen-presenting cells pulsed with tumor extracts.

Publication ,  Journal Article
Nair, SK; Snyder, D; Rouse, BT; Gilboa, E
Published in: Int J Cancer
March 17, 1997

Vaccination with tumor extracts circumvents the need to identify specific tumor rejection antigens and extends the use of active immunotherapy to the vast majority of cancers, in which specific tumor antigens have not yet been identified. In this study we examined the efficacy of tumor vaccines comprised of unfractionated tumor material presented by professional antigen-presenting cells (APC): dendritic cells (DC) or macrophages (M phi). To enhance the relevance of these studies for human patients we used 2 poorly immunogenic murine tumor models and evaluated the effectiveness of the vaccination protocols in tumor-bearing animals. APC (in particular DC) pulsed with unfractionated extracts from these "poorly immunogenic" tumors were highly effective in eliciting tumor-specific cytotoxic T lymphocytes. A measurable CTL response could be detected after even a single immunization with tumor extract-pulsed DC. DC or M phi pulsed with tumor extract were also effective vaccines in tumor-bearing animals. In the murine bladder tumor (MBT-2) model a modest extension of survival and 40% cure rate was seen in the animal groups immunized with DC or M phi pulsed with MBT-2 tumor extract. DC or M phi pulsed with B16/F10.9 tumor extract were also remarkably effective in the B16 melanoma lung metastasis model, as shown by the observation that treatment with APC caused a significant reduction in lung metastases. Cumulatively, the CTL and immunotherapy data from the two murine tumor systems suggest that APC (in particular DC) pulsed with unfractionated cell extracts as a source of tumor antigen may be equally or more effective than genetically modified tumor vaccines.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Int J Cancer

DOI

ISSN

0020-7136

Publication Date

March 17, 1997

Volume

70

Issue

6

Start / End Page

706 / 715

Location

United States

Related Subject Headings

  • Vaccination
  • Tumor Cells, Cultured
  • T-Lymphocytes, Cytotoxic
  • Oncology & Carcinogenesis
  • Neoplasms, Experimental
  • Mice, Inbred C57BL
  • Mice
  • Macrophages
  • Immunotherapy, Active
  • Female
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Nair, S. K., Snyder, D., Rouse, B. T., & Gilboa, E. (1997). Regression of tumors in mice vaccinated with professional antigen-presenting cells pulsed with tumor extracts. Int J Cancer, 70(6), 706–715. https://doi.org/10.1002/(sici)1097-0215(19970317)70:6<706::aid-ijc13>3.0.co;2-7
Nair, S. K., D. Snyder, B. T. Rouse, and E. Gilboa. “Regression of tumors in mice vaccinated with professional antigen-presenting cells pulsed with tumor extracts.Int J Cancer 70, no. 6 (March 17, 1997): 706–15. https://doi.org/10.1002/(sici)1097-0215(19970317)70:6<706::aid-ijc13>3.0.co;2-7.
Nair SK, Snyder D, Rouse BT, Gilboa E. Regression of tumors in mice vaccinated with professional antigen-presenting cells pulsed with tumor extracts. Int J Cancer. 1997 Mar 17;70(6):706–15.
Nair, S. K., et al. “Regression of tumors in mice vaccinated with professional antigen-presenting cells pulsed with tumor extracts.Int J Cancer, vol. 70, no. 6, Mar. 1997, pp. 706–15. Pubmed, doi:10.1002/(sici)1097-0215(19970317)70:6<706::aid-ijc13>3.0.co;2-7.
Nair SK, Snyder D, Rouse BT, Gilboa E. Regression of tumors in mice vaccinated with professional antigen-presenting cells pulsed with tumor extracts. Int J Cancer. 1997 Mar 17;70(6):706–715.
Journal cover image

Published In

Int J Cancer

DOI

ISSN

0020-7136

Publication Date

March 17, 1997

Volume

70

Issue

6

Start / End Page

706 / 715

Location

United States

Related Subject Headings

  • Vaccination
  • Tumor Cells, Cultured
  • T-Lymphocytes, Cytotoxic
  • Oncology & Carcinogenesis
  • Neoplasms, Experimental
  • Mice, Inbred C57BL
  • Mice
  • Macrophages
  • Immunotherapy, Active
  • Female